CHG-2022-0179

Specification Change for Atezolimumab-R. Facility Change for Atezolimumab-R — major revision. Impacts 6 markets and 2 variations.

Change Number
CHG-2022-0179
Type
Specification Change
Product
Atezolimumab-R
Status
Submitted
Owner
Lieselotte van der Berg
Initiated
2023-04-24
Description

Facility Change for Atezolimumab-R — major revision

Impacted Markets (6)
US — United StatesJP — JapanGB — United KingdomIT — ItalyES — SpainAT — Austria
Impacted Modules
4.2.12.3.P3.2.P3.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved